Gelonghui November 28 | Tailong Pharmaceutical (600222.SH) stated on the investor interactive platform that the company does not have azithromycin-related products yet; currently, the company's business is operating normally, paying close attention to market demand for Shuanghuanglian oral liquid, and rationally organizing production and guaranteeing supply.
太龙药业(600222.SH)：暂无阿奇霉素相关产品
Tailong Pharmaceutical (600222.SH): No azithromycin-related products
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.